Solopharm (Grotex OOO) – Russian pharmaceutical company, which produces liquid sterile dosage forms according to GMP standards (license № 00023-LS). Product line consists of infusion and injection solutions, ophthalmic, otolaryngological, gastroenterological, rheumatological and cosmetological products.
History
Solopharm company was established in 2010. The owner and director of Solopharm company is Russian businessman Oleg Zherebtsov. In August 2014 – launch of injection and infusion solution lines by the innovative technology Blow-Fill-Seal accepted in the world as the most perfect technology for production of sterile solutions with opportunity to use aseptic filling or finish sterilization. Solopharm company continues building and assembling new lines to increase the amount of liquid medicines in ophthalmology, otolaryngology, gastroenterology, rheumatology and cosmetology.
Activity
The company activity is directed to development and production of:
- Products in polyethylene and polypropylene packaging
- Generics in different therapeutic areas
- Own brands of drugs and medical products
Product Lines
- Ophthalmology
- Rheumatology
- Otolaryngology
- Pulmonology
- Cosmetology
- Gastroenterology
- Injection solutions
- Infusion solutions
References
- "Фармзавод Solopharm инвестирует 32 млн евро в строительство третьей очереди". Фармацевтический вестник. 2015-09-22. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
- Елена Кром, Наталья Доброва (2015-05-15). "О.Жеребцов: от продуктового ретейла до производства вакцин". РБК. Archived from the original on 2016-03-05. Retrieved 2016-04-16.
- Богдан Боколейко (2015-10-05). "Первая конференция компании Solopharm для СМИ. Репортаж канала Санкт-Петербург". Бизнес Петербург. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
- "Два инвестиционных проекта получили статус стратегических". Новотека. 2016-01-11. Archived from the original on 2016-03-05. Retrieved 2016-04-18.